On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Arrhythmia: Substrate Ablation Has Benefits
Substrate-based ablation (in which all damaged areas of the lower heart muscle are treated) has advantages over ablation of clinical ventricular tachycardia (in which the origin of the abnormal rhythm is pinpointed, then the target tissue is scarred with electrical current). Researchers at Montefiore Einstein Center for Heart and Vascular Care report on a study.
Is Major Depressive Disorder Characterized by Two Distinct States?
Researchers have suggested that major depressive disorder (MDD) is a "nonlinear dynamic phenomenon with two discrete states." If so, then treatment can be more effectively tailored based on which state of MDD patients are in.
Study results show patients with atrial fibrillation who stopped taking warfarin before surgery received no benefit from temporary "bridging" with low-molecular-weight heparin. Patients who received no anticoagulation while off warfarin did not experience significantly more thromboembolic events, but they did experience significantly lower fewer incidents of serious bleeding.
Study Finds No Link Between Acne Treatment Isotretinoin and Depression Risk
Researchers reported that treatment with isotretinoin is not only associated with significant clinical improvement in patients with moderate to severe acne, but it also did not cause worsening of depression or suicidal thoughts in any of the patients in the study.
Treating 5 Percent of All Patients with Hepatitis C Would Reduce Costs and Total Infections
October 8th 2015Comparing current treatment models to lessons learned in the early days of the AIDs epidemic, University of Southern California researchers are advocating that more than just the sickest patients with hepatitis C be treated with new drugs that have much higher cure rates than past regimens.
Migraine Risk Higher in Patients with Low Back Pain
The risk of developing migraine is increased for those who have low back pain, a low level of education, a heavy physical workload, or participate in heavy recreational activities, but is decreased for those who drink alcohol frequently.
FDA Requires Manufacturers to Investigate Infection Risk Associated with Duodenoscope Use
The US Food and Drug Administration requested three manufacturers of duodenoscopes – Olympus America, Inc. Fujifilm Medical Systems, USA, Inc., and Hoya Corp – to perform real-world postmarket surveillance studies duodenoscopes used to perform endoscopic retrograde cholangiopancreatography procedures (ERCP).
Degenerative Cervical Myelopathy: Does Age Matter?
October 7th 2015Clinicians often discourage older patients with degenerative cervical myelopathy from pursuing surgery, worrying that lingering pathology, comorbidities, reduced physiological reserves, and age-related spinal cord changes will delay recovery.
Antipsychotics Worsen Outcomes in Parkinson's Disease Psychosis
October 7th 2015Research shows that treatment with atypical antipsychotics appears to significantly increase the risk of mortality and severe adverse events among patients with Parkinson's disease psychosis (PDP), when compared to patients with PDP who did not receive antipsychotics.
What Can Retinal Abnormalities Tell Us About Major Depressive Disorder?
A recent study showed that retinal abnormalities detected through objective electrophysiological measurements may help identify the pathogenesis of major depressive disorder and possibly other psychological conditions.
Filtered Sunlight is Safe and Noninferior to Phototherapy in Neonatal Hyperbilirubinemia Patients
The use of filtered sunlight is both safe and noninferior to conventional phototherapy for the treatment of neonatal hyperbilirubinemia. This is important because severe neonatal hyperbilirubinemia can lead to fatal complications, and because in some cases, existing guidelines for managing neonatal hyperbilirubinemia explicitly discourage the use of sunlight for the treatment.